fbpx

Migraine Clinical Trial

Now Open in Sioux City, IA

A migraine is characterized by moderate-to-severe episodic unilateral pulsating headaches that last for 4 to 72 hours. Typical characteristics of the headache are unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea and/or sensitivity to light (photophobia) and sound (phonophobia).

If you suffer from migraines, sign up to learn more about an investigational nasal powder medication study near you.

Eligible participants…

  • Must be age 18 to 65
  • Must have experienced 2 to 8 migraines per month in each of the past 3 months
  • Will have experienced migraines before turning age 50
  • Will receive compensation for study-related time
  • Do not need insurance to join this study
  • May receive study-related exams at no cost

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (712) 639-6200.

Submit your information

Expect Excellence icon - supporting research since 1999

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.

© 2020 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy